Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company, is currently making waves in the biotech sector with its promising pipeline of cancer therapies. With a market capitalization of $1.1..
Abivax SA (ABVX), a prominent player in the biotechnology sector, has recently captured the attention of investors, particularly with a remarkable potential upside of 17.4%. As a clinical-stage biotech company..
Investors keen on exploring the frontier of mental health treatment may find COMPASS Pathways Plc (NASDAQ: CMPS) an intriguing prospect. As a biotechnology company at the cutting edge of mental..
Cross Country Healthcare, Inc. (NASDAQ: CCRN) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. Based in Boca Raton, Florida, the company offers comprehensive..
For investors keen on the healthcare sector, AngioDynamics, Inc. (NASDAQ: ANGO) presents an intriguing opportunity, particularly with its potential upside of 72.62%, as indicated by the current analyst ratings. With..
Emergent BioSolutions Inc. (NYSE: EBS) is carving out a niche in the healthcare sector as a provider of solutions for public health threats, ranging from pandemics to bioterrorism. This Maryland-based..
MBX Biosciences, Inc. (MBX), a burgeoning force in the biotechnology sector, is making waves with its innovative approach to addressing endocrine and metabolic disorders. While currently trading at $37.26, the..
Standard BioTools Inc. (NASDAQ: LAB), a key player in the healthcare sector’s medical devices industry, offers a compelling opportunity for investors seeking growth in the biotechnological arena. Headquartered in South..
Oruka Therapeutics, Inc. (NASDAQ: ORKA) is currently capturing the attention of investors with its impressive 71.70% potential upside. As a clinical-stage biopharmaceutical company, Oruka is at the forefront of developing..
Arvinas, Inc. (ARVN), a prominent player in the biotechnology sector, is capturing the attention of investors with its innovative approach to tackling disease-causing proteins. The company, based in New Haven,..
In the dynamic landscape of regenerative medicine, Organogenesis Holdings Inc. (NASDAQ: ORGO) is carving a niche with its innovative portfolio targeting advanced wound care and surgical applications. With a market..
PureTech Health plc (PRTC), a player in the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to cutting-edge healthcare innovations. With a market cap of approximately $436.96 million,..
Kamada Ltd. (NASDAQ: KMDA), a prominent player in the healthcare sector, specializes in manufacturing plasma-derived protein therapeutics. Headquartered in Rehovot, Israel, Kamada’s diverse product portfolio addresses various critical medical needs,..
Treace Medical Concepts, Inc. (NASDAQ: TMCI), a pioneering company in the healthcare sector, specifically within the medical devices industry, has been capturing investor attention with its innovative solutions for bunion..
For investors with a keen eye on the biotechnology sector, Rapport Therapeutics, Inc. (NASDAQ: RAPP) presents a compelling opportunity, particularly with a projected potential upside of 70.80%. The Boston-based clinical-stage..
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology firm, is capturing the attention of investors with its notable potential upside of 57.33%, according to analyst ratings. With a market capitalization..
Celcuity Inc. (NASDAQ: CELC), a clinical-stage biotechnology company, is making waves in the healthcare sector with its innovative approach to cancer treatment. With a market capitalization of $4.94 billion, Celcuity..
AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company headquartered in San Diego, California, is capturing investor attention with an enticing 22.46% potential upside, as indicated by the latest analyst ratings...
Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, specifically within the medical devices industry, has caught the eye of investors with a robust potential upside of 69%..
Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company based in San Diego, California, is gaining significant attention from investors with its potential for substantial upside. As a key player..
